pulmonary arterial hypertension treatment

Ads
related to: pulmonary arterial hypertension treatment
PAH Treatment Option - Potential Drug Interactions

www.pah-hcp.com
Read Potential Drug Interactions. See If PAH Treatment Is Right For Your Adult Patients. Before Prescribing A PAH Treatment Option, Review Important Safety Information.
Types: Financial Assistance Info, Dosing & Titration Info, Diagnostic Resources
Treatment Information
Consider This Option as Part

Of Your Treatment Algorithm.

Identifying PAH Patients
See Patient Profiles To Understand

When To Consider This Treatment.

PAH Basics
Get Resources to Help Assess

And Monitor PAH Adult Patients.

Diagnostic Resources
Resources To Help You Diagnose,

Assess & Treat Your Patients.

Enrollment Forms
Access Treatment Initiation and

Patient Support Forms.

Patient Support Program
Learn About a Program That

Supports Patients on Treatment.
Learn About PAH - PAH Progression Info

pahtreatmentsupport.com
Visit Official Site to Learn More About a Potential Treatment Option for PAH. Learn About Potential Treatment Option for PAH By Visiting HCP Site.
Safety Profile · Prescription Assistance · Instructions for Use · HCP Resources
Types: Safety Info, Prescribing Info, Cost Support Info, Dosing Info
What Is PAH
Start Treatment Option
Enroll in REMS
A DUE Trial

Search results

- The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
  Investor's Business Daily· 11 hours ago
  The company makes a handful of drugs for chronic diseases. Its biggest drug is Tyvaso, a treatment...
- Why 93% Of This Biotech's Value Just Went Up In Smoke
  Investor's Business Daily· 4 days ago
  Wedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
- Supreme Court of Canada dismisses Apotex’s application for leave to appeal macitentan inducing...
  JD Supra· 3 days ago
  The patent claims macitentan in combination with a phosphodiesterase type-5 inhibitor (for example, tadalafil) to treat diseases where vasoconstriction is involved, including pulmonary ...
- Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
  Zacks via Yahoo Finance· 4 days ago
  Aerovate's (AVTE) shares plunge 93% as its lead candidate, AV-101, fails to meet the primary and...
- Aerovate scraps late-stage development of lead drug for lung disease
  Reuters via AOL· 5 days ago
  The drug developer's sole product, called AV-101, did not help improve blood flow from the lungs to the heart in patients with pulmonary arterial
- Keros Therapeutics reshuffles leadership team By Investing.com
  Investing.com· 4 days ago
  Keros Therapeutics, Inc. (NASDAQ:KROS), a biopharmaceutical company engaged in developing treatments...
- Reviva Pharmaceuticals (NASDAQ:RVPH) Given Buy Rating at HC Wainwright
  ETF DAILY NEWS· 2 days ago
  Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently ...
- Check Out What Whales Are Doing With INSM - Insmed (NASDAQ:INSM)
  Benzinga· 1 day ago
  The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl...inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil ...
- The 3 Best Medical Device Stocks to Buy in June 2024
  InvestorPlace· 1 day ago
  Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical...
- Aerovate Therapeutics (NASDAQ:AVTE) Downgraded to “Inline” at Evercore ISI
  ETF DAILY NEWS· 3 days ago
  Evercore ISI cut shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) from an outperform rating to an inline rating in a research note released on Tuesday morning, Marketbeat reports.